Delivery Order SPE2DR25D3104-SPE2DR26FE8YY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,388.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,571.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 2, 2025. This competitive delivery order, utilizing firm fixed pricing with no set-aside designation, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,946.33 on November 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by November 13, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution and healthcare supply operations...
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $31,043.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 8, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,765.60 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order is set to be completed by December 3, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract under a larger indefinite delivery contract (IDC) vehicle. This delivery...
- The Defense Logistics Agency awarded a $2,287.74 delivery order to AmerisourceBergen Drug Corp on February 11, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is classified as firm fixed price with no set-aside designation, indicating it was awarded through open competition. Performance will be completed by February 12, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $399,725.26 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pen (0.5 mL). This competitive award, which carries a firm fixed price structure, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE8YYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,107.42 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed price, competitively awarded contract is classified as a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. No set-aside designation was applied to this procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide. The current delivery order for Zepbound represents one of numerous pharmaceutical procurement actions fulfilled under this expansive contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities supporting Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/8/25 |